Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial

Chronic hepatitis B (CHB) remains a major worldwide public health concern. Besifovir dipivoxil maleate (BSV) is a new promising treatment for CHB. However, long-term efficacy and safety have not yet been evaluated. Therefore, the goal of the study is to determine the antiviral efficacy and safety of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Gastroenterol
Main Authors: Yim, Hyung Joon, Kim, Won, Ahn, Sang Hoon, Yang, Jin Mo, Jang, Jae Young, Kweon, Yong Oh, Cho, Yong Kyun, Kim, Yoon Jun, Hong, Gun Young, Kim, Dong Joon, Jung, Young Kul, Um, Soon Ho, Sohn, Joo Hyun, Lee, Jin Woo, Park, Sung Jae, Lee, Byung Seok, Kim, Ju Hyun, Kim, Hong Soo, Yoon, Seung Kew, Kim, Moon Young, Lee, Kwan Sik, Lim, Young Suk, Lee, Wan Sik, Han, Kwang-Hyub
Formato: Artigo
Idioma:Inglês
Publicado: Wolters Kluwer 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402376/
https://ncbi.nlm.nih.gov/pubmed/32355123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000605
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares